Lonza Group Ltd Share Price Other OTC
Equities
LZAGY
US54338V1017
Biotechnology & Medical Research
Sales 2024 * | 6.66B 7.33B 613B | Sales 2025 * | 7.55B 8.31B 694B | Capitalization | 37.24B 40.99B 3,425B |
---|---|---|---|---|---|
Net income 2024 * | 887M 976M 81.57B | Net income 2025 * | 1.09B 1.2B 100B | EV / Sales 2024 * | 6 x |
Net Debt 2024 * | 2.71B 2.99B 249B | Net Debt 2025 * | 3.17B 3.49B 292B | EV / Sales 2025 * | 5.35 x |
P/E ratio 2024 * |
41.9
x | P/E ratio 2025 * |
33.7
x | Employees | - |
Yield 2024 * |
0.87% | Yield 2025 * |
1% | Free-Float | 95.87% |
Latest transcript on Lonza Group Ltd
Managers | Title | Age | Since |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 25/17/25 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 01/21/01 |
Maria Nunez
COO | Chief Operating Officer | 55 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 16/14/16 |
Director/Board Member | 66 | 16/14/16 | |
Marion Helmes
BRD | Director/Board Member | 58 | 05/22/05 |
1st Jan change | Capi. | |
---|---|---|
+26.37% | 44.96B | |
-1.01% | 42.65B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B | |
+20.21% | 11.72B |